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Abstract
Objectives: To compare the clinical and cost-effectiveness of face-to-face (FTF) with over-the-telephone (OTT) delivery of
low intensity cognitive behavioural therapy.
Design: Observational study following SROBE guidelines. Selection effects were controlled using propensity scores. Non-
inferiority comparisons assessed effectiveness.
Setting: IAPT (improving access to psychological therapies) services in the East of England.
Participants: 39,227 adults referred to IAPT services. Propensity score strata included 4,106 individuals; 147 pairs
participated in 1:1 matching.
Intervention: Two or more sessions of computerised cognitive behavioural therapy (CBT).
Main outcome measures: Patient-reported outcomes: Patient Health Questionnaire (PHQ-9) for depression; Generalised
Anxiety Disorder questionnaire (GAD-7); Work and Social Adjustment Scale (WSAS). Differences between groups were
summarised as standardised effect sizes (ES), adjusted mean differences and minimally important difference for PHQ-9. Cost
per session for OTT was compared with FTF.
Results: Analysis of covariance controlling for number of assessments, provider site, and baseline PHQ-9, GAD-7 and WSAS
indicated statistically significantly greater reductions in scores for OTT treatment with moderate (PHQ-9: ES: 0.14; GAD-7: ES:
0.10) or small (WSAS: ES: 0.03) effect sizes. Non-inferiority in favour of OTT treatment for symptom severity persisted as small
to moderate effects for all but individuals with the highest symptom severity. In the most stringent comparison, the one-to-
one propensity matching, adjusted mean differences in treatment outcomes indicated non-inferiority between OTT versus
FTF treatments for PHQ-9 and GAD-7, whereas the evidence was moderate for WSAS. The per-session cost for OTT was
36.2% lower than FTF.
Conclusions: The clinical effectiveness of low intensity CBT-based interventions delivered OTT was not inferior to those
delivered FTF except for people with more severe illness where FTF was superior. This provides evidence for better targeting
of therapy, efficiencies for patients, cost savings for services and greater access to psychological therapies for people with
common mental disorders.
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Introduction
The programme to improve access to psychological therapies
(IAPT) is the most significant development in English mental
health services since the closure of the asylums and the advent of
community care. Whilst those developments concerned severe
mental illness and secondary care, IAPT targets mild to moderate
depression and anxiety. These are common conditions seen
frequently in general practice [1,2]; they cause enormous disability
at the population level [3,4]. The financial cost of depression in the
UK was estimated at approximately 150 billion pounds in 2009/
2010, of which 30 billion is thought to be related to inability to
work [1].
Predicated on economic arguments and clinical evidence, IAPT
promotes access to talking treatments based on cognitive
behavioural therapy (CBT) approved by the National Institute of
Clinical Excellence (NICE). IAPT services solicit referrals (includ-
ing self-referral) and reduce waiting times [1,2] for CBT by
substantially increasing the numbers of therapists. More than 300
new therapists were recruited between 2008 and 2011 in the East
of England (EoE) alone. Maintaining or increasing the working
capacity of patients are important secondary goals that underpin
economic arguments for IAPT [1]. There are two tiers of IAPT
therapy, depending on clinical severity, and corresponding to
NICE steps 2 and 3 for the treatment of depression and anxiety.
More intense therapy is delivered by more experienced clinicians
in the higher tier. The present study concerns the lower tier that
provides treatment for the majority of referrals from primary care
and other sources.
Two IAPT demonstration sites in England (Newham and
Doncaster) provided observational evidence that face-to-face
(FTF) and over-the-telephone (OTT) delivery of psychological
therapy were both effective in depression and anxiety [3]. Brief,
CBT-based interventions led to significant reductions in symptoms
of a magnitude similar to that reported in specialist out-patient
psychotherapy services [4,5]. These findings are in line with a
randomised controlled trial of telephone CBT [6] and a recent
non-inferiority trial comparing OTT with FTF interventions for
obsessive compulsive disorder [7,8].
Telephone mediated psychological interventions are convenient
for patients and therapists, with a 40% reduction in treatment time
[7,8] and removal of barriers to treatment [9]. Services are no
longer constrained by working hours or treatment space.
However, the evidence for these benefits relies on small samples
in specialised settings, and may not be relevant to the relatively
brief interventions (fewer than six sessions) delivered in the lower
tier of IAPT [10].
OTT may represent a cost-effective option for IAPT. Both
OTT and FTF services have already been implemented by the
National Health Service across England, preventing the assess-
ment of comparative effectiveness of mode of delivery of the
therapy through randomised designs at the individual or even
cluster (therapist or service) level. Therefore, we employed a
stepped approach to the analysis of observational data, attempting
to minimise the disadvantages of a non-randomised design and
maximise the information relevant to the assessment of compar-
ative effectiveness of OTT and FTF therapy. We used patient-
rated outcomes from 190,128 treatment sessions within IAPT sites
in the EoE to compare the clinical and cost effectiveness of low
intensity, CBT-based psychological interventions delivered OTT
versus FTF.
Methods
Ethics Statement
The study design and database were reviewed by the National
Research and Ethics Service (NRES) for England. NRES
considered the work to be an evaluation of existing services using
anonymised clinical record data and did not require further ethical
review.
Setting and participants
All subjects entered treatment after referral to IAPT services
commissioned by seven primary care trusts (PCTs; organisations
charged with commissioning care from health providers) in the
EoE region from September 2008 until September 2010. These
were: NE Herts, NE Essex, Suffolk, W Herts and Mid Essex,
Bedfordshire, and Cambridgeshire. These are referred to in a
different order as services A–G. All had been providing treatment
for longer than 12 months at the time of data extraction; five
remaining PCTs delivering IAPT services in the EoE had yet to
achieve this stability and were excluded.
All services implemented a stepped-care model: patients could
receive either high or low intensity interventions, as deemed
appropriate by a standard initial assessment. We focused our
analysis on patients treated exclusively with low intensity
interventions where OTT is a treatment option for trained
therapists working in accordance with service implementation
guidelines [11]. Six low intensity interventions, alone or in
combination, were approved for delivery either FTF or OTT, a
decision taken by the therapist at assessment in collaboration with
the patient; there were no operational guidelines. The low
intensity interventions were computerised cognitive behavioural
therapy (C-CBT), books on prescription or guided self-help,
behavioural activation, structured physical exercise, or attendance
at psycho-educational groups.
Individuals were excluded from the analysis if they:
a) received or were scheduled to receive one or more high
intensity treatments (defined as either receiving visits marked
as high intensity and/or receiving treatments associated with
a high intensity interventions);
b) attended fewer than two sessions;
c) attended fewer than two sessions in which the outcome
measures (psychometric rating scales assessing depression,
anxiety) were completed;
d) had no recorded treatment outcome;
e) had more than a single recorded session of behavioural
activation or structured exercise.
For the cost-minimisation analysis, information about number
and type of treatment sessions were extracted from the clinical
data while IAPT cost information, also anonymised, was extracted
from reports prepared by Mental Health Strategies for the
Department of Health [12]. The evaluation was funded and
supported by NHS East of England and the NIHR CLAHRC for
Cambridgeshire & Peterborough. The design, analyses and
drafting of this manuscript were undertaken in accordance with
STROBE guidelines [13].
Defining intervention groups: CBT delivered over-the-
telephone (OTT) or face-to-face (FTF)
People referred to IAPT underwent a routine, baseline face-to-
face assessment after which subjects were allocated to high or low
intensity treatment, thereafter. The treatment comparison groups
Face-to-Face versus over the telephone CBT
PLOS ONE | www.plosone.org 2 September 2012 | Volume 7 | Issue 9 | e42916
for this study were derived from those allocated to low intensity
treatments who were themselves, divided between FTF therapy,
where all subsequent sessions were face-to-face, and therapy given
Over-The-Telephone OTT. This latter group includes a small
number of people who did not receive the routine FTF baselines
assessment because a single IAPT service provider arranged for
this to be undertaken by the referrer (see Results); subjects in the
OTT group received all subsequent therapy OTT regardless of
where the initial assessment took place. Subjects who, following
assessment, received a mixture of FTF and OTT therapies were
excluded from the analysis.
Patient-reported Outcomes (PROs)
Three PROs are mandated for use in patient evaluation as per
IAPT implementation guidelines [11]. They are measured at
baseline assessment and before each subsequent treatment session.
Patients complete the three outcome measures themselves, either
on paper or on screen, as they prefer. The scores are available for
discussion between the therapist and patient during the subsequent
treatment session, whether OTT or FTF. Neither therapists nor
patients were aware that the current comparative effectiveness
study would take place.
The Patient Health Questionnaire Depression scale
(PHQ-9). Nine questions assess symptoms of depression and
are scored from 0 (‘‘Not at all bothered by the problem’’) to 3
(‘‘Bothered nearly every day’’). Sum scores range from 0 to 27. A
score of 10 has been suggested as a cut point for a clinical diagnosis
of depression [14]; severity bands for symptoms levels in terms of
PHQ-9 scores are shown later in Results, Table 1.
The Generalised Anxiety Disorder scale (GAD-7). Seven
items measure the severity of anxiety symptoms [15] using the
same response options and item scores as the PHQ-9. Sum scores
range from 0 to 21. A score of 8 or higher on the GAD-7 has been
suggested as a threshold for a likely diagnosis of clinical anxiety
[15]. Severity bands applicable to GAD-7 scores are shown in
Table 1.
The Work and Social Adjustment Scale (WSAS). Five self-
report items regarding ability to work, home management, social
leisure, private leisure and close relationships are each scored 0–8;
zero indicates no impairment and eight is very severe impairment.
The total score assesses overall functional impairment [16].
Severity bands are: 0–10 subclinical impairment; 10–20 functional
impairment; 20–30 moderately severe impairment; 30+ severe
impairment.
Analytical Approaches
We used three approaches to analyse these observational data.
The first approach involved naı¨ve comparisons between PROs
for FTF and OTT treatments (unadjusted and adjusted, as
described below). The second and third approaches used sampling
methods based on propensity scores. This allowed us to adjust for
potential confounding in the non-randomised design, particularly
concerning selection by assessing clinicians of patients with certain
characteristics to either FTF or OTT. These propensity methods
allowed ‘‘matched’’ non-inferiority comparisons across the two
groups using the patient-reported outcomes: symptom reduction
(depression and anxiety), work and social adjustment. A cost-
minimisation analysis based on treatment duration and previous
estimates of per session costs was used to compare the cost
implications of OTT and FTF sessions.
Approach 1: Naı¨ve treatment comparisons. As a first step,
differences in FTF versus OTT treatment effectiveness were
assessed using an unadjusted ANCOVA model with only
treatment as a factor. A second adjusted model controlling for
baseline symptom severity (as measured using PHQ9, GAD7, and
WSAS baseline scores), PCT, and treatment duration (represented
as the number of attended sessions) was then developed.
Approaches 2 & 3: Propensity Score Development. In
observational, non-randomised evaluations, naı¨ve comparisons
between individuals who receive different treatments (FTF vs.
OTT) are confounded; treatment choice is influenced by an
individual’s baseline clinical, social, or behavioural factors that
may themselves affect the outcome, independent of treatment
allocation. A propensity score approach attempts to mitigate this
selection bias by balancing as many observed covariates (which
potentially influence selection to treatment) as possible across
treatments, increasing the validity of comparisons between non-
randomised treatment groups.
In this analysis, the propensity score represents the probability
of receiving OTT rather than FTF treatment conditional on
covariates entered into a logistic regression model. Covariates
included demographic indicators (age and gender), baseline
measures of symptom severity, work, social adjustment, and
service level predictors. Three binary coded items assessing the
presence of general or specific phobias were also included.
Employment, benefit status, receipt of psychotropic medication
at baseline, and referral source was also included. PCT (indicating
a particular IAPT service or set of commissioned services) was
included in the model to ensure that treatment selection was not
biased by differences in treatment effectiveness or policy regarding
OTT use. Other service characteristics entered included referral
source and also how long the service had been operating when the
patient was seen.
Individuals receiving different treatments with similar propen-
sity scores can be considered matched and their outcomes can be
directly compared. Unlike randomised designs, the assumption
that covariates included in the propensity model largely account
for treatment selection requires careful examination of regression
results.
Given that baseline characteristics were routinely assessed but
not always systematically recorded (lack of recording occurred in
approximately 15% of cases), missing baseline data were imputed
using corresponding variables collected at the second visit so as to
increase the available analysis sample.
Deriving the matched on propensity score samples for
comparison
The two separate propensity score matching approaches used
probability estimates resulting from the model. In Approach 2,
patients were assigned to one of five strata based on probability
estimates such that propensity for OTT vs. FTF was minimal
within strata and maximal between. Those in the first stratum
were similar to individuals receiving OTT interventions; those in
the fifth stratum were similar to individuals receiving FTF
treatment (see Results). Effectiveness of the OTT versus FTF
intervention was compared between treatments within each
stratum.
Approach 3 used nearest-neighbour, 1:1, non-replacement
matching to assess the sensitivity of the stratification approach.
Each individual receiving OTT treatment was matched to an
individual receiving FTF treatment with a near equivalent
propensity score. Once matched, both individuals were removed
from the sample and the process repeated until no further pairs
could be matched. This process produced two samples with
identical sample sizes matched on propensity score values, but
excluding a large number of unmatched individuals.
The 1:1 matching was conducted within each of the seven PCTs
to control for differences in the magnitude of the symptom change
Face-to-Face versus over the telephone CBT
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Table 1. Baseline demographic, clinical, and functional characteristics of patients receiving either face-to-face or predominantly
telephone based treatments.
Variable
Face-to-Face therapy (FTF)
(n =1791)
Over-the Telephone therapy
(OTT) (n =2315)
N % N %
Age in years* ,18–25 274 15.3 384 16.6
26–35 437 24.4 532 23.0
36–45 444 24.8 591 25.5
46–55 373 20.8 417 18.0
56–65 209 11.7 265 11.4
66–85 56 3.1 127 5.5
Gender Female 1144 63.8 1526 65.9
Employment* Full-Time 838 46.7 1037 44.8
Part-Time 327 18.2 444 19.2
Unemployed – seeking or occupied 310 17.3 321 13.9
Inactive 318 17.7 514 22.2
Benefits/Sick pay Receiving at baseline 416 23.2 497 21.5
Period of time in ,3 Months 93 5.2 31 1.3
mental health 3–6 Months 87 4.9 96 4.1
services at first 7–9 Months 84 4.7 170 7.3
IAPT session 10–12 Months 55 3.1 182 7.9
12+ Months 1474 82.2 1837 79.3
Psychotropic medication* Use at baseline 966 53.9 1167 50.4
Referral source* GP referral 1675 93.4 1874 80.9
Self-referral 41 2.3 238 10.3
Any specialty 31 1.7 127 5.5
Other 46 2.6 77 3.3
PCT* A 53 3.0 755 32.6
B 672 37.5 21 0.9
C 247 13.8 33 1.4
D 191 10.7 886 38.3
E 534 29.8 90 3.9
F 53 3.0 312 13.5
G 43 2.4 219 9.5
PHQ-9 score* No Impairment (0–5) 212 11.8 247 10.7
Mild Impairment (5–9) 408 22.8 499 21.5
Moderate Impairment (10–14) 455 25.4 681 29.4
Moderate-Severe Impairment (15–19) 422 23.5 567 24.5
Severe Impairment (20–27) 296 16.5 322 13.9
GAD-7 score No Impairment (0–5) 193 10.8 223 9.6
Mild Impairment (5–9) 451 25.2 594 25.6
Moderate Impairment (10–14) 530 29.6 708 30.6
Severe Impairment (15–21) 619 34.5 791 34.2
Mean SD Mean SD
WSAS score 16.4 9.1 15.2 8.9
Phobia Measures Phobia Q1* 2.9 2.5 2.6 2.4
Phobia Q2* 2.5 2.7 2.1 2.5
Phobia Q3 2.2 2.7 2.1 2.6
*: Significant differences across treatment groups.
doi:10.1371/journal.pone.0042916.t001
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and differences in the balance of OTT and FTF implementation
across providers. To ensure that services with a larger treatment
volume or more matches did not bias the results, each service
contributed the same number of matched pairs to the sample
(n = 21 pairs; see Results), including all the matched pairs from the
PCT with the smallest number. For the remainder, we drew
random sub-samples with the same number of pairs (n = 21 pairs).
Results were verified by repeatedly re-sampling the matched pairs
with replacement.
The level of tolerable difference in 1:1 matching was specified a
priori using a value for the calliper estimate which determines the
width of the propensity score interval. We adopted a conservative
value of the logit (0.2 standard deviations).
Statistical comparisons
To compare baseline and treatment characteristics between
OTT and FTF, independent sample t-tests were used for
differences in continuous outcomes. Chi-square or Fisher’s exact
tests were used for categorical/dichotomous variables. Within
each stratum and 1:1 matching sample, a random-effects
ANCOVA model using the same covariates in the adjusted
comparisons was used to compare the two treatments in terms of
the three PROs: PHQ-9, GAD-7 and WSAS. Effect size (ES)
estimates (Cohen’s d) were provided with all OTT and FTF
comparisons. Using established guidelines, ES values less than 0.10
were considered small, 0.11 to 0.25 were considered moderate,
and those above 0.25 were considered large.
To assess non-inferiority between the treatments we used two-
sided significance tests and 95% confidence intervals for score
differences between treatment groups on all three outcome
measures. The lower limit of the confidence interval (LCL)
represents a boundary of non-inferiority. For all three measures,
the LCLs were compared with small (0.2 x pooled S.D.) and
medium (0.5 x pooled S.D.) estimates of statistical uncertainty. For
the PHQ-9 depression scale, the minimally important difference
estimate of 5 units was an additional measure with which to assess
non-inferiority and the importance of any differences between
treatments [17].
Assessing cost-effectiveness
Data on session volume and corresponding total spend was
available for five of the seven PCTs for financial year 2009/2010,
allowing us to estimate OTT and FTF session costs. A cost-
minimisation approach was selected on the basis of treatment
equivalence [18]. The reported total spend on IAPT in each PCT
was divided into a cost for low and high intensity activity. Initial
micro-costing data indicated low intensity activity was 1.8 times
less expensive than high intensity; representative but anonymous
data from a PCT are available from the authors. A local tariff
developed for IAPT services in the EoE region also confirmed that
the cost ratio was closer to this estimate [19]. The proportion of
low intensity sessions were adjusted for this base-case cost ratio of
1.8, providing a cost estimate of all low intensity activity. The 1.8
ratio was also varied from 1.2 to 2.0 to test the assumption’s
sensitivity.
Literature reports indicated that OTT requires shorter treat-
ment durations than FTF [8,9]. To derive the cost per OTT and
FTF session the difference in session duration was assumed to
directly translate into an equivalent difference in cost. We used an
observed ratio of 1.5 for the difference in treatment duration
observed between FTF and OTT to calculate cost per session. The
estimated total cost for all low intensity sessions was apportioned
based on the proportion of OTT and FTF sessions for each PCT,
adjusting for the 1.5 ratio to arrive at the total cost of OTT and
FTF. Dividing the total costs by the number of sessions provided
session costs for each treatment.
Results
Patient flow, follow-up, and sample characteristics
Patient flow is described in Figure 1. During the survey period,
39,227 individuals were referred to IAPT services in seven PCTs.
Of those, 21,452 (55%) attended at least two sessions during which
treatment was administered: 11,401 (53%) of those received or
were scheduled to receive a high intensity intervention, leaving
10,051 (47%) individuals receiving solely low intensity interven-
tions. Of these people allocated to low intensity interventions,
6,873 (68%) had information on baseline and endpoint measures
and all baseline covariates required for propensity score matching
and calculation of change scores. These were the potential
participants in this study.
The 6,873 potential participants were then divided into three
groups based on receipt of OTT and/or FTF therapy:
1. The FTF group: 2560 people (32.3%) received exclusively FTF
therapy; of these, 1791 (70%) had completed treatment at the
time of data extraction and comprise the FTF group.
2. The OTT group: 2928 (46.0%) received only OTT interventions
after a baseline FTF assessment (this included 311 people from
a single IAPT service who received their baseline FTF
assessment by the referrer, not that IAPT service); of these,
2315 (79%) had completed treatment at the time of data
extraction and comprise the OTT group.
3. The remaining 1385 (21.7%) participants received a blend of
OTT and FTF interventions and could not be reliably
allocated to either treatment group; this third group of people
receiving low-intensity interventions were excluded from our
analyses.
Differences in baseline attributes across treatment
groups. Table 1 displays baseline characteristics for both
treatment groups before propensity score matching. The FTF
group was more likely to be unemployed, referred by a general
practitioner (family medical practitioner; GP) and to be receiving
psychotropic medication at baseline. More people received FTF in
PCTs B, C, and E. Individuals receiving FTF were also more likely
to report moderately-severe or severe scores on the PHQ-9 and to
have slightly higher average WSAS scores. Those who received
OTT interventions were more likely to be economically inactive
(e.g. student or homemaker). OTT interventions were more likely
to have been received in PCTs A, D, and F. Small but significant
differences were observed across groups in terms of age
distribution, active service duration at first visit, and phobia
questions 1 and 2.
Comparison of outcomes for CBT delivered OTT versus
FTF
Propensity score estimates (odds of OTT vs. FTF) are shown in
Table 2. Older age was associated with FTF treatment. Individuals
were less likely to receive OTT interventions if they were
unemployed. The longer an IAPT service had been in operation,
the more likely OTT interventions were to be used. Receipt of
OTT treatment was less likely if the individual was seen in PCTs
B, C, D and E relative to the reference provider (A). The model R-
square was 0.50, indicating excellent predictive accuracy.
Approach 1: Naı¨ve Comparisons. Figure 2 displays the
mean reduction in PHQ-9, GAD-7 and WSAS for both OTT and
FTF treatments in the overall sample (unadjusted and adjusted for
Face-to-Face versus over the telephone CBT
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provider, number of treatment sessions), each propensity stratum,
and the 1:1 matching sample. An unadjusted comparison shown in
the top section indicated significant differences between treatments
in the reductions of PHQ-9 and GAD-7 symptom scores; OTT
interventions appeared to be more effective (PHQ-9: F = 17.5,
p,.001, effect size (ES) = 0.13; GAD-7: F = 5.93, p = 0.015,
ES = 0.07; WSAS: F = 2.82, p = 0.087, ES = 0.04). Significant
differences between treatment groups on both symptom measures
were still observed after controlling for number of assessments,
provider sites, and baseline symptom severity measures (PHQ-9:
F = 10.9, p,.001, ES = 0.14, GAD-7: F = 8.13, p = 0.042,
ES = 0.10, WSAS: F = 3.12, p = 0.078, ES = 0.03).
Approach 2: Propensity Scores & Stratification
Approach. Five propensity strata were developed using esti-
mated propensity scores. This approach minimizes differences in
propensity to being prescribed OTT vs. FTF by restricting the
Figure 1. Flow and selection of subject records for inclusion into naı¨ve comparisons and propensity score analyses.
doi:10.1371/journal.pone.0042916.g001
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Table 2. Logistic regression of OTT versus FTF generating estimates and standard errors for variables included in the propensity
score.
Variable Estimate S.E. 95% confidence T-test p-value
Lower Upper
Age in years ,18–25 ****
26–35 20.18 0.17 20.50 0.15 21.06 0.29
36–45 20.19 0.17 20.52 0.14 21.14 0.25
46–55 20.47 0.17 20.81 20.12 22.68 0.01
56–65 20.34 0.20 20.73 0.05 21.72 0.09
66–85 20.53 0.28 21.08 0.01 21.92 0.06
Gender Female 0.02 0.11 20.20 0.24 0.21 0.84
Employment Full-Time ****
Part-Time 0.14 0.15 20.15 0.42 0.94 0.35
Unemployed – seeking or occupied 20.42 0.16 20.74 20.11 22.61 0.01
Inactive 0.07 0.15 20.23 0.37 0.44 0.66
Benefits/Sick pay Receiving at baseline 20.20 0.14 20.48 0.07 21.46 0.14
Period of time in ,3 Months ****
mental health 3–6 Months 0.01 0.37 20.72 0.74 0.03 0.98
services at first 7–9 Months 0.65 0.36 20.06 1.35 1.79 0.07
IAPT session 10–12 Months 1.02 0.38 0.29 1.76 2.72 0.01
12+ Months 2.04 0.44 1.17 2.90 4.62 ,0.01
Psychotropic medication Use at baseline 20.07 0.10 20.27 0.13 20.67 0.50
Referral source GP referral ****
Self-referral 0.22 0.21 20.20 0.63 1.02 0.31
Any specialty 0.25 0.34 20.41 0.91 0.74 0.46
Other 20.51 0.29 21.08 0.06 21.75 0.08
PCT A ****
B 26.19 0.27 26.71 25.66 223.0 ,0.01
C 23.36 0.36 24.06 22.66 29.39 ,0.01
D 21.09 0.17 21.43 20.76 26.44 ,0.01
E 24.51 0.19 24.89 24.13 223.5 ,0.01
F 0.56 0.41 20.24 1.36 1.38 0.17
G 0.15 0.39 20.62 0.91 0.38 0.70
PHQ-9 score No Impairment (0–5) ****
Mild Impairment (5–9) 20.02 0.20 20.42 0.37 20.12 0.91
Moderate Impairment (10–14) 20.01 0.22 20.43 0.41 20.05 0.96
Moderate-Severe Impairment
(15–19)
20.13 0.24 20.60 0.33 20.57 0.57
Severe Impairment (20–27) 20.37 0.26 20.89 0.15 21.40 0.16
GAD-7 score No Impairment (0–5) ****
Mild Impairment (5–9) 20.05 0.20 20.45 0.35 20.24 0.81
Moderate Impairment (10–14) 20.19 0.21 20.61 0.22 20.91 0.36
Severe Impairment (15–21) 20.10 0.23 20.55 0.34 20.45 0.66
WSAS score No Impairment (0–10) ****
Mild Impairment (11–20) 20.18 0.13 20.44 0.08 21.32 0.19
Moderate Impairment (21–30) 20.21 0.16 20.53 0.10 21.32 0.19
Severe Impairment (31–40) 20.12 0.26 20.63 0.38 20.47 0.64
Phobia measures Phobia Q1 20.03 0.02 20.07 0.02 21.16 0.25
Phobia Q2 20.01 0.02 20.05 0.04 20.32 0.75
Phobia Q3 0.00 0.02 20.04 0.04 0.11 0.92
Note: Values in bold indicate significant associations (p,.01).
doi:10.1371/journal.pone.0042916.t002
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treatment comparison to subjects within each stratum where these
propensity characteristics are similar (Table 3). There were 821
individuals in all strata except the third, in which there were
n = 822. The number of individuals receiving OTT interventions
in each stratum were 758 (93.6%) in the first stratum, 705 (88.5%)
in the second, 642 (80.1%) in the third, 139 (17.3%) in the fourth,
Figure 2. Average reductions in PHQ-9, GAD-7 and WSAS scores for FTF versus OTT therapy groups. Reductions in PHQ-9, GAD-7 and
WASAS are each shown in a different pane. Comparisons between the reductions in the FTF and OTT groups shown by paired bars; OTT is always the
upper and FTF the lower. These are presented first for the overall sample (adjusted and unadjusted; the first, naı¨ve approach to analysis), then for the
five propensity strata, and last for the 1:1 matching procedure. Other than the first, unadjusted reductions, all average reductions (in the strata
comparisons and in the 1:1 matching) are adjusted for service provider, number sessions administered, and baseline symptom severity for the
particular measure (PHQ9, GAD7 or WSAS). See: http://www.psychiatry.cam.ac.uk/wp-content/uploads/2012/08/PONE-D-11-20688-Figures.doc for
colour version.
doi:10.1371/journal.pone.0042916.g002
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Table 3. Patient characteristics in the five propensity score strata.
Propensity Stratum
One n=821 Two n=821 Three n=822 Four n=821 Five n=821
n (%)
Age in years ,18–25 175 (21.3) 111 (13.5) 117 (14.2) 146 (17.8) 109 (13.3)
26–35 180 (21.9) 206 (25.1) 176 (21.4) 191 (23.3) 216 (26.3)
36–45 230 (28.0) 212 (25.8) 183 (22.3) 211 (25.7) 198 (24.1)
46–55 110 (13.4) 144 (17.5) 195 (23.7) 150 (18.3) 191 (23.3)
56–65 87 (10.6) 94 (11.4) 105 (12.8) 89 (10.8) 98 (11.9)
66–85 39 (4.8) 54 (6.6) 46 (5.6) 34 (4.1) 9 (1.1)
Gender Female 583 (71.0) 517 (63.0) 523 (63.6) 529 (64.4) 517 (63.3)
Employment Employment- Full-Time 377 (45.9) 393 (47.9) 332 (40.4) 375 (45.7) 397 (48.4)
Employment- Part-Time 183 (22.3) 158 (19.2) 126 (15.3) 165 (20.1) 139 (16.9)
Unemployed – seeking or occupied 63 (7.7) 91 (11.1) 193 (23.5) 118 (14.4) 165 (20.1)
Inactive 198 (24.1) 179 (21.8) 171 (20.8) 163 (19.9) 120 (14.6)
Benefits/Sick pay Receiving at baseline 43 (9.4) 69 (16.6) 69 (22.9) 85 (14.8) 143 (23.2)
Period of time in ,3 Months 0 0 79 (9.6) 33 (4.0) 335 (40.8)
mental health 3–6 Months 2 (0.2) 80 (9.7) 219 (26.6) 195 (23.8) 127 (15.5)
services at first 7–9 Months 172 (21.0) 196 (23.9) 186 (22.6) 159 (19.4) 75 (9.1)
IAPT session 10–12 Months 55 (6.7) 175 (21.3) 250 (30.4) 138 (16.8) 71 (8.6)
12+ Months 592 (72.1) 370 (45.1) 88 (10.7) 296 (36.1) 213 (25.9)
Psychotropic medication Use at baseline 397 (48.4) 412 (50.2) 429 (52.2) 429 (52.3) 464 (56.5)
Referral source GP referral 617 (75.2) 677 (82.5) 684 (83.2) 798 (97.2) 771 (93.9)
Self-referral 81 (9.9) 102 (12.4) 84 (10.2) 8 (1.0) 4 (0.5)
Any specialty 94 (11.4) 27 (3.3) 14 (1.7) 6 (0.7) 17 (2.1)
Other 29 (3.5) 15 (1.8) 40 (4.9) 9 (1.1) 29 (3.5)
PCT A 560 (68.2) 176 (21.4) 70 (8.5) 1 (0.1) 0
B 0 0 0 122 (14.9) 571 (69.5)
C 0 0 0 191 (23.3) 89 (10.8)
D 158 (19.2) 374 (45.6) 517 (62.9) 27 (3.3) 0
E 0 0 0 462 (56.3) 161 (19.6)
F 57 (6.9) 164 (20) 135 (16.4) 9 (1.1) 0
G 46 (5.6) 107 (13.0) 100 (12.2) 9 (1.1) 0
PHQ-9 score No Impairment (0–5) 125 (15.2) 67 (8.2) 55 (6.7) 119 (14.5) 93 (11.3)
Mild Impairment (5–9) 234 (28.5) 142 (17.3) 142 (17.3) 209 (25.5) 178 (21.7)
Moderate Impairment (10–14) 242 (29.5) 268 (32.6) 218 (26.5) 210 (26.5) 197 (24.0)
Moderate-Severe Impairment (15–19) 163 (19.9) 226 (27.5) 223 (27.1) 170 (27.1) 207 (25.2)
Severe Impairment (20–27) 57 (6.9) 118 (14.4) 184 (22.4) 113 (22.1) 146 (17.8)
GAD-7 score No Impairment (0–5) 125 (15.2) 39 (4.8) 60 (7.3) 116 (14.1) 76 (9.3)
Mild Impairment (5–9) 242 (29.5) 198 (24.1) 184 (22.4) 222 (27.0) 198 (24.1)
Moderate Impairment (10–14) 213 (25.9) 282 (34.3) 270 (32.8) 206 (25.1) 265 (32.3)
Severe Impairment (15–21) 241 (29.4) 302 (36.8) 308 (37.5) 277 (33.7) 282 (34.3)
WSAS score No Impairment (0–10) 380 (46.3) 241 (29.4) 213 (25.9) 297 (36.2) 196 (23.9)
Mild Impairment (11–20) 286 (34.8) 334 (40.7) 313 (38.1) 304 (37.0) 324 (39.5)
Moderate Impairment (21–30) 131 (16.0) 195 (23.8) 243 (29.6) 172 (21.0) 227 (27.6)
Severe Impairment (31–40) 24 (2.9) 51 (6.2) 53 (6.4) 48 (5.8) 74 (9.0)
Mean (SD)
Phobia Measures Phobia Q1 Mean (SD) 2.2 (2.1) 2.7 (2.4) 3.2 (2.6) 2.6 (2.4) 3.1 (2.6)
Phobia Q2 Mean (SD) 1.8 (2.3) 2.2 (2.5) 2.4 (2.6) 2.4 (2.6) 2.7 (2.8)
Phobia Q3 Mean (SD) 1.9 (2.6) 2.1 (2.6) 2.3 (2.7) 2.0 (2.6) 2.2 (2.7)
doi:10.1371/journal.pone.0042916.t003
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and 16 (2.0%) in the fifth. Strata differed markedly in their
demographic, baseline symptom, and service characteristics, these
factors being related to the odds of receiving OTT vs. FTF
treatment.
Stratum one, which included those most likely to receive telephone
interventions, had the lowest overall age and the highest
percentage of women (71%) of all five strata. It also had the
lowest average PHQ-9, GAD-7, and WSAS scores in addition to
the lowest average scores for each phobia measure. 68% of
individuals were employed (full or part-time) and 9.4% of
individuals were receiving benefits. The majority of individuals
in the stratum were seen 12 months or longer after the service
initiated. Slightly less than half received psychotropic medication
at baseline. It also contained the lowest proportion of patients
referred by GPs (75%). Providers were not proportionately
represented across strata.
Compared with stratum one, stratum two comprised a slightly
older population with a smaller proportion of women (63%).
PHQ-9, GAD-7, WSAS scores, and all phobia scores were
markedly higher than stratum one. Percentage of individuals in full
or part time employment was similar to stratum one (67%),
although a higher proportion of individuals received benefits
(16.6%). 45% of individuals were seen more than 12 months after
the service was initiated. 83% of individuals were GP referrals.
Stratum three had age and gender characteristics similar to
stratum two (63.6% women) with significantly higher average
PHQ-9 scores but comparable GAD-7, WSAS scores. Average
phobia scores were higher than strata one and two. 55.7% of
individuals were employed (lowest of all strata), and 22.9% of
individuals were receiving benefits at baseline. Only 10% of
individuals were seen after the service had been active for longer
than 12 months. 83.2% of individuals were referred by their GP.
Stratum four had the second-oldest age profile and the second-
highest proportion of women (64.4%). PHQ-9, GAD-7, and
WSAS scores were slightly lower than strata two and three, similar
to stratum one. Average phobia measures were similar to stratum
two. 65.8% of individuals were in full or part-time employment at
baseline; 14.8% were receiving benefits. 97% of individuals in
stratum four were referred by GPs, and only 36.1% of individuals
were seen after the service had been active for longer than
12 months.
Stratum five was most like stratum three in terms of its age and
gender distribution (63.3% women); it had the highest PHQ-9,
GAD7, and WSAS scores of all. Phobia scores were high, also
similar to stratum three. 65.6% of individuals were in part or full-
time employment and 23.2% of individuals were receiving benefits
at baseline. 25.9% individuals were seen after services had been
active for longer than 12 months.
Significant differences in baseline means for PHQ-9 between
treatments were observed only in stratum one (t-statistic: 2.34,
p = 0.02). No significant baseline differences were observed in
GAD-7 and WSAS across treatment groups in any stratum. All
group average scores for GAD-7 and PHQ-9 indicated moderate
impairment (10–14) while all group average WSAS scores were
between 10 and 20, indicating functional impairment.
Figure 2 displays the average score reduction within each
stratum for all three outcome measures. Figure 3 displays adjusted
mean differences in score reduction between OTT and FTF
treatment so as to assess non-inferiority. In strata one to three, the
lower confidence limit (LCL) of the adjusted mean difference did
not fall below 0.2 S.D. on any of the measures; this is strong
evidence that neither treatment was inferior to the other. In
stratum four (and in the 1:1 propensity matching, see below) the
LCL for adjusted mean difference in WSAS exceeded the 0.2 S.D.
threshold, indicating only marginal support for non-inferiority
regarding work and social adjustment improvement. The situation
was different in stratum five, the group with most severe
symptoms. Here, the LCL exceeded 0.2 and 0.5 S.D. for the
PHQ-9 and GAD-7 scores and 0.2 S.D. for the WSAS, indicating
potentially superior symptom reduction in all domains for
individuals receiving FTF interventions.
The minimally important difference (MID) estimate of 5 points
on the PHQ-9 [17] is represented by the extreme limits of the x-
axis in Figure 3 for this outcome measure (25 favouring FTF and
+5 favouring OTT). No estimates or LCL approached this MID
estimate although some statistically differences between OTT and
FTF groups were apparent. In strata 2 and 3, reductions in PHQ-
9 scores were significantly larger for individuals receiving OTT
versus FTF interventions (Stratum two: F: 4.05, p = .045, ES: 0.22,
Stratum three: F: 4.09, p = .043, ES: 0.18). The average reduction
in GAD-7 scores for those receiving OTT interventions was
significantly higher in stratum two (F: 4.20, p = .041, ES: 0.22).
Thus, whether they favoured OTT or FTF, any statistically
significant effects identified in the comparisons within strata were
small to medium (as defined as Cohen’s d estimates between 0.10
and 0.25) and, for PHQ-9, below the threshold defined as a
minimally important difference.
Approach 3: Non-inferiority Comparisons & 1:1
Matching. The 1:1 matching procedure produced the following
numbers of matched pairs in each PCT: A: 53, B: 21, C: 29, D:
186, E: 77, F: 53, G: 37. The lowest number of matched pairs was
21 (42 individuals) from site B. Thus, 21 matched pairs were
repeatedly and randomly selected from the six other PCTs so as to
produce, always together with the 21 pairs from site B, 40 samples
of 147 pairs (Table 4). All univariate comparisons of matching
variables across treatment groups were non-significant (data not
presented).
Baseline PHQ-9 and GAD-7 mean scores for both OTT and
FTF interventions indicated moderate depression and anxiety
(PHQ-9: 13.0 and 11.6, GAD-7: 12.0 and 10.9 for OTT and FTF,
Figure 3. Adjusted mean differences in PHQ-9, GAD-7 & WSAS measures shown as effect sizes. To assess non-inferiority between the
treatments we used two-sided significance tests and 95% confidence intervals for score differences between treatment groups. The first pane is a key
to the other six that show the results for the five strata (analysis approach 2) and for the 1:1 matched sample (approach 3). The lower limit of the
confidence interval (LCL) represents a boundary of non-inferiority. For all three measures, the LCLs were compared with two estimates of statistical
uncertainty: small (0.2x pooled SD; inner vertical line closer to line of equivalence) and medium (0.5x pooled SD; outer line). The next six panes display
adjusted mean differences in score reduction between OTT and FTF treatment assessing non-inferiority. In strata one to three, the lower confidence
limit (LCL) of the adjusted mean difference fell below 0.2 SD on none of the measures, indicating strong evidence that neither treatment was inferior
to the other. In stratum four and in the 1:1 propensity matching, the WSAS LCL exceeded the 0.2 SD threshold, indicating only marginal support for
non-inferiority regarding work and social adjustment improvement. The situation was different in stratum five, the group with most highest symptom
scores, where the LCL exceeded 0.2 and 0.5 SD for the PHQ-9 and GAD-7 scores and 0.2 SD for the WSAS. This indicates potentially superior symptom
reduction in all domains for individuals receiving FTF CBT. The a priori minimally important difference (MID) estimate of 5 points on the PHQ-9 is
represented by the extreme limits of the x-axis in Figure 3 (25 favouring FTF and +5 favouring OTT). No estimates or LCL approached this MID
estimate. Furthermore, the effect size is small for all the potential differences, including those reaching statistical significance in strata 2 and 3. See:
http://www.psychiatry.cam.ac.uk/wp-content/uploads/2012/08/PONE-D-11-20688-Figures.doc for colour version.
doi:10.1371/journal.pone.0042916.g003
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respectively). WSAS baseline means indicated functional impair-
ment (16.17 and 14.76, respectively). No significant difference in
the baseline average values across groups was observed. (PHQ-9 t-
score: 21.91, p = 0.06, GAD-7 t-score: 21.625, p = 0.11, WSAS t-
score: 1.29, p = 0.20).
Figure 2 displays the average score reduction in the 1:1
matching sample for all three measures (bottom pair of bars in
each panel). The bottom right pane in Figure 3 summarises
adjusted differences in treatment outcomes between OTT and
FTF treatment administration in the 1:1 matched sample. WSAS
exceeded the 0.2 S.D. LCL, indicating marginal equivalence.
PHQ-9 and GAD-7 did not, indicating that neither OTT nor FTF
was an inferior treatment to the other. As for the within strata
comparisons, the lower limit of the confidence interval for the
PHQ-9 did not exceed the five point change estimate that would
have indicated the possibility of a minimally important difference
between scores.
Results from the random-effects ANCOVA revealed no
significant difference in the magnitude of reductions in PHQ-9
(OTT: 5.6 (6.4), FTF: 4.8 (5.3)), GAD-7 (OTT: 5.1 (6.0), FTF: 4.8
(5.3)), and WSAS (OTT: 5.4 (9.1), FTF: 5.7 (8.2)); (PHQ-9 F:
2.185, p = 0.140, GAD-7 F: 0.576, p = 0.449, WSAS F: 0.004,
p = 0.994).
Treatment characteristics and course in the FTF and
OTT groups matched 1:1 on the basis of propensity
scores. Table 4 provides information on the type, duration,
and content of treatments provided in both treatment groups
derived from the sensitivity analysis (random draws). For all
outcomes, reported proportions were taken from a single,
representative random draw while significance levels were
calculated using iterative re-sampling of matched pairs.
No significant difference was observed across groups in terms of
type of treatment outcomes (average x2: 3.73, average p = 0.375,
95% CI: 0.296–0.454, indicating no difference in the manner in
which patients terminated treatment across groups. Those
receiving OTT interventions were significantly more likely to
receive computerised CBT (average x2: 16.30, average p,0.001,
95% CI: 0.001–0.002). Those receiving OTT interventions were
less likely to receive psycho-educational group interventions,
although the difference was marginal (average x2: 4.565,
p,0.005, 95% CI: 0.048–0.096). All other treatment type
comparisons were non-significant. No significant differences across
groups in the number of modalities received during the course of
treatment were observed (average x2: 1.27, p,0.005, 95% CI:
0.690–0.798).
No significant difference was observed in the number of
treatments received (average t-statistic: 0.2, p = 0.84, 95% CI:
0.55–0.80), although a significant difference in the total duration
of treatment was observed (average t-statistic: 3.74, p,0.001, 95%
CI: ,0.001–0.210). On average, individuals receiving OTT
treatment received 32.6% less contact time than equivalent FTF
patients.
Cost-minimisation Analysis
Under the assumption that OTT costs 32.6% (approx.
1.5 times) less than FTF, the cost per session was estimated for a
base-case scenario (Table 5). The mean cost per session for OTT
was £79.19 (95% CI 55.0 to 103.3) and FTF was £ 118.76 (95%
CI 82.5 to 155.0). Even when the cost ratio was varied from
1.2 times to 2 times, OTT was still cost-effective.
Discussion
This comparison of talking therapies delivered OTT or FTF
was a naturalistic study in established, low intensity IAPT services
across an entire region of England; the sample size is large and
Table 4. Treatment characteristics and course in FTF versus OTT groups matched 1:1 on the basis of propensity scores.
Measure of treatment characteristics & course
Face-to-Face (FTF)
n=147
Over-the-Telephone
(OTT) n=147
Mean p-value (95% CI) 40
replications
N (%) % N (%) %
Service outcome Completed treatment 77 52.4 70 47.6
Declined treatment 11 7.5 16 10.9
Dropped out of treatment 43 29.3 52 35.4
Not Suitable for treatment 16 10.9 9 6.1 0.375 (0.296–0.454)
Therapy modality Computerised CBT 13 8.8 43 29.3 0.001 (0.001–0.002)
in patients Pure Self-Help 94 63.9 87 59.2 0.524 (0.516–0.532)
receiving at least Guided Self-Help 77 52.4 65 44.2 0.137 (0.080–0.194)
one session Behavioural Activation 29 19.7 20 13.6 0.387 (0.290–0.484)
Structured Exercise 27 18.4 11 7.5 0.379 (0.283–0.475)
Psycho-educational Groups 10 6.8 3 2.0 0.072 (0.048–0.096)
Number of 1 61 41.5 77 52.4
Therapy modalities 2 54 36.7 50 34.0
received during 3 23 15.6 13 8.8
treatment course 4+ 9 6.1 7 4.8 0.744 (0.690–0.798)
Mean SD Mean SD
Mean number of treatment sessions 3.88 2.03 3.93 2.11 0.844 (0.549–0.922)
Mean total treatment duration (hours:minutes, SD in mins.) 03:27 159 02:20 84 ,0.001 (,0.001–0.210)
Note: Values in bold indicate significant associations (p,.01).
doi:10.1371/journal.pone.0042916.t004
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uses routine, systematic and prospectively collected patient-
reported outcomes. Existing evidence for the effectiveness of
talking therapies based on CBT for mild to moderate depression
and anxiety is strong and based on gold-standard randomised
controlled trials (RCTs); the same is true for therapy delivered
over the telephone. However, these trials are predominately in the
context of small samples from research-based clinical settings. On
the basis of Government mandate, IAPT services have been
introduced at great pace throughout England, negating the
possibility of extending the evidence from RCTs to the question
as to whether CBT or its mode of delivery (e.g. FTF or OTT) are
clinically- or cost-effective when scaled-up from the clinical
laboratory to the entire population. In these circumstances, where
even cluster randomisation is impossible, a range of further
methodologies must be deployed in order to assess the compar-
ative effectiveness of health services [22]. The results of
observational studies need to be interpreted with great care
because of potential bias and confounding. Nevertheless, it is
important to exploit the information from routinely collected
information in order to inform policy makers, clinicians and
patients in the common circumstances that are beyond rando-
mised trials.
In this vein, we have carefully applied a series of analytical
approaches to the question of comparative effectiveness in
common mental disorders of CBT delivered face-to-face or
over-the-telephone in a network of health services that are
already in place. We believe that some conclusions can be drawn
and recommendations made for further work. The first analytical
approach, a naı¨ve comparison between is presented for
completeness and in order to show how findings develop and
the approach becomes more sophisticated. The following
propensity score approaches militate against bias and confound-
ing resulting from selection to treatment effects such as the
systematic use of one treatment modality or another according to
characteristics of the particular IAPT service or individual
participants.
The two propensity score approaches compared the efficacy of
the two treatments in individuals who were similar in their
baseline treatment profiles and controlled for systematic differ-
ences between providers of the IAPT service. We demonstrated
that OTT and FTF showed equivalent effectiveness for anxiety
symptoms (GAD-7), depression symptoms (PHQ-9), and work
and social functioning (WSAS) in all but the most severely
affected patients who were identified within stratum five. Initial,
unadjusted comparisons suggested OTT was actually more
effective than a FTF approach but these results were heavily
contaminated by selection to treatment effects and should be
discounted in favour of results from the propensity approaches.
Strengths and Limitations of the study
Major strengths include the regional setting across several
services, use of routine PROs and the large number of covariates
available for the propensity score. Despite exclusions due to lack of
treatment and missing data, the sample is much larger than
comparable RCTs that often have sample selection effects, limited
generalizability and unsatisfactory comparison groups such as
waiting list controls. Subjects were inevitably excluded from the
propensity sampling but each individual stratum and the 1:1
matched sample amount to some of the largest samples ever used
to assess the effectiveness of telephone based interventions in
routine psychological care. Reliance on comparisons with
individuals on a waiting list and seen in routine GP care are a
recognised weakness in the current literature assessing telephone
based psychological interventions [6]. Our results are widely
applicable given that the sample was drawn from a range of
different IAPT providers implementing different service structures
and treatment models, with individual participants representing a
broad cross-section of the population within an English region.
The study has limitations. We cannot be certain whether the
benefits seen across both groups were genuine effects of the IAPT
treatment or were due to natural resolution of symptoms and
regression to the mean. However, the CBT interventions have
been shown to have efficacy in well-designed RCTs so it is a
reasonable assumption that there were real treatment effects to be
compared. There may be a degree of hidden bias and residual
confounding due to un-assessed covariates (including unimagined
factors) that would have been equalised in a randomised design;
patient safety, mobility and previous illness history represent
possible factors here. We see the rating of the outcomes by
patients, themselves, as a positive aspect of the study. The
measures were used in the same way in the two treatment arms
and neither patients nor clinicians were aware that the comparison
of FTF and OTT would subsequently be made. Independent,
blind assessments by a third party would have been a useful
corroboration but were impractical in an in-service evaluation
such as this. The representativeness of the data remains a concern;
those individuals who fail to report all of the items on the IAPT
minimum dataset may be more (or less) likely to drop-out of
treatment or to experience less symptom reduction. This can be
better assessed as further data accrue in a wider range of IAPT
service system providers.
Another limitation is that the effectiveness of OTT and FTF
interventions cannot be assessed according to an exact clinical
Table 5. Cost per session for over-the-telephone (OTT) and face-to-face (FTF) therapies in IAPT during 2009–2010.
PCT
Total IAPT Spend
(£)
Total Spend on
Low Intensity Total Costs Total Sessions Mean Session Cost (£)
Sessions (£) OTT FTF OTT FTF OTT FTF
A 2,029,000 752,835 416,462 336,373 5432 2925 76.67 115.01
B 2,188,000 978,790 53,632 925,158 867 9971 61.86 92.79
C 2,521,000 829,835 124,921 704,914 1160 4365 107.65 161.48
D 4,050,000 1,269,143 447,933 821,210 7293 8914 61.42 92.13
E 2,647,000 984,611 125,695 858,916 1424 6488 88.26 132.39
Mean Session Cost (95% CI) 79.19 (55 to 103) 119 (83 to 155)
doi:10.1371/journal.pone.0042916.t005
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diagnosis given likely differences in diagnostic accuracy and
conventions across the numerous health-care professionals within
the sample of providers. All that can be said is that telephone-
based interventions are effective in the treatment of many
individuals presenting to the lower intensity tier of IAPT services
in the East of England. The vast majority of these people will have
mixed anxiety and depression, sometimes referred to as common
mental disorder. Nevertheless, the accuracy and standardisation of
clinician diagnosis and possible differential effects of treatment
according to more detailed diagnostic categories remain important
areas of future research, albeit that these are unlikely ever to be
used consistently on a large scale.
A fifth of potentially eligible subjects were excluded because
they received a mixture of FTF and OTT treatments following
their baseline assessment. It would have been useful to have
included these subjects on the basis of an intention-to-treat
analysis. This was not possible because we had no indication of
what the intention was; we could have allocated subjects to either
OTT or FTF on the basis of the nature of their contact in the
session following baseline, but this would have been an assumption
of intention that may not have been warranted. It is likely that
mixtures of FTF and OTT arise because of the uncertainty as to
which may be better, something our study was intended to resolve,
or because the true intention was a blend of treatment, a third
treatment arm.
The total sample size was large but became restricted as the
analysis moved into the propensity strata and the 1:1 matched
sample. Thus, the statistical power needs consideration. We were
careful to ground the analyses in the context of conventionally
defined effect sizes and, for the measure of depression, the PHQ-9,
in an accepted definition of a minimally important difference [17]
that equates to a large effect size. Thus, we can be clear from our
results that we have not rejected such a treatment difference or
greater on the basis of a Type II statistical error; none of the
confidence limits in the 1:1 analysis approached such a difference
and a post-hoc power analysis indicated that this analysis was
sufficiently powered, with conventional parameters, to exclude,
had they existed, a large effect for PHQ-9 (ES 0.27) and moderate
effects for GAD-7 and WSAS (ES 0.16 and 0.24, respectively).
A limitation of the costing approach adopted is that it was
primarily based on assumptions concerning estimates of the
relative costs of OTT and FTF treatments. Given that the costs of
IAPT are largely the costs of staff and clinical facilities, with
education costs being similar in both groups, it is likely that our
results based on staff time will be valid, with differences remaining
similar even if a more detailed micro-costing approach was to be
undertaken. Estimates of cost savings are also incomplete;
additional savings in the form of reduced travel and reduced
need for clinical accommodation remain important considerations
to be incorporated into future calculations. Our view is that these
would magnify the differences that we have observed.
The findings
Our results indicate that symptoms decrease and social function
increases under both treatment conditions, and that OTT is a
convenient and effective CBT modality for the majority of patients
treated within the lower intensity tier of IAPT services. There was
an important indication of heterogeneity of effect: the propensity
strata showed that those who were older and had higher symptom
scores (stratum 5) may do better with FTF. This conclusion has
face validity given that these people would be closest to the
threshold for the more intensive IAPT therapies given face-to-face
that are not the subject of this study that concentrated on lower
intensity treatments.
Thus, for the majority, the convenience of OTT to patients and
services embeds a likely economic advantage to OTT for most
people. The cost-minimisation analysis focused on service costs,
alone. It indicated that the cost per OTT session was approx-
imately one third lower than that of a FTF session, a result that
was robust when the model assumptions were changed. The
delivery of OTT or FTF therapy appeared to depend not on
patient characteristics but mainly on where and when the
treatment took place. This suggests that it is within the remit of
commissioners and services to design IAPT services, accordingly,
though further work is needed to define the characteristics of those
people with severe disorder, such as those in stratum five, who will,
in fact, do better with a FTF model. Overall, the results indicate
that increasing the proportion of low intensity talking therapy
delivered OTT in some areas may reduce the cost of the IAPT
programme, increase its productivity and maintain the quality of
the service. Further research is needed to better identify the group
of people with more severe illness in stratum 5, initially assessed
clinically as appropriate for the lower level therapies; they may
have better outcomes with FTF therapy.
Comparison with other studies. A recent meta-analysis
[20] demonstrated benefits for the use of technology-mediated
interventions in the treatment of depression and anxiety, but only
two studies compared telephone with face-to-face delivery. One
RCT of 72 patients showed that CBT delivered by telephone was
equivalent to treatment delivered face-to-face with similar levels of
satisfaction.[7]. This study involved OCD sufferers, a specific
anxiety disorder, and highly trained therapists akin to those in the
higher intensity IAPT tier. A meta-analysis comparing the effect of
self-guided interventions with brief therapeutic input, common in
the IAPT low intensity setting, found that brief contact did boost
effectiveness [10] but FTF or OTT contacts were not compared.
Nevertheless, our large-scale, pragmatic evaluation of IAPT in a
real-world setting is consistent with the findings of the prior work,
strengthening the case for action.
The results from the 1:1 stratification sample indicated that
OTT interventions can provide significant reductions in the total
amount of time each patient is seen. Our estimates were somewhat
lower than the 40% reported in other published accounts but
further efficiencies may be found as services mature (our IAPT
services had been established for only 1–2 years) and if more
attention is paid to the design of the OTT approach [7]. Layard
and colleagues, seminal contributors to the original IAPT model,
estimated that the cost of providing a standard course of roughly
ten sessions of CBT is £750 or £75 per session [21], an assumed
rather than an observed estimate. Our OTT session costs
estimates exceed this but still represent a significant route for cost
savings and effective, flexible, and readily available treatment.
Conclusions and Policy Implications
The clinical effectiveness of low intensity CBT-based interven-
tions delivered over-the-telephone was not inferior to those
delivered face-to-face in the majority of patients with the common
mental disorders of depression and anxiety. A minority of people
with more severe illness and who tended to be older appeared to
gain more benefit from face-to-face therapy; research is required
in order for services to identify them efficiently. For most, CBT
delivered over-the-telephone is a cost-effective and probably
convenient option, providing the potential for significant financial
savings to the IAPT programme in the lower intensity context.
Increasing the proportion of low intensity talking therapy delivered
over-the-telephone may reduce the cost of the IAPT programme,
increase its productivity and maintain the quality of the service.
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In a global context, the potential is enormous for spreading
access to effective psychological therapies to the millions of people
affected by depression and anxiety. As the availability of mobile
phone technology in low and middle income countries grows,
people now have the potential of having a therapist in their pocket,
transcending traditional barriers to the receipt of effective
treatments. Should this opportunity be taken we recommend that
randomised evaluations are used to evaluate what could poten-
tially amount to another major step forward in care for common
mental disorders.
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